ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 204

$1.24M Total Retail Price of All Prescriptions

Rank: 3 out of 204

716 Patients Receiving at Least One Drug in Part D
28% Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

21% of this provider’s 716 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
ALPRAZOLAM 2,794 495 322 10 B 1 4
AMPHETAMINE SALT COMBO 917 107 113 S2 10 2 26
ZOLPIDEM TARTRATE 782 247 104 3 12
TRAZODONE HCL 744 146 142 4 2
TEMAZEPAM 659 104 100 B 5 29
CLONAZEPAM 512 114 86 B 6 1
FLUOXETINE HCL 486 111 73 7 8
CARISOPRODOL 474 42 54 R 8 58
QUETIAPINE FUMARATE 467 59 78 A 9 5
CYMBALTA 457 91 78 10 13
RISPERIDONE 435 96 83 A 11 3
LAMOTRIGINE 408 45 79 12 16
DIAZEPAM 395 94 64 B 13 23
CITALOPRAM HBR 339 87 69 14 15
LORAZEPAM 297 94 54 B 15 9
BUPROPION XL 290 82 49 16 20
SERTRALINE HCL 289 47 53 17 7
LITHIUM CARBONATE 288 53 51 18 21
BUPROPION HCL SR 280 75 51 19 32
PAROXETINE HCL 279 76 44 20 31
VENLAFAXINE HCL ER 249 85 48 21 19
MIRTAZAPINE 233 91 36 22 17
GABAPENTIN 223 53 45 23 22
CARBAMAZEPINE 166 44 33 24 42
AMITRIPTYLINE HCL 154 55 28 R 25 44
DIVALPROEX SODIUM ER 143 13 27 26 10
OLANZAPINE 130 41 26 A 27 11
ESCITALOPRAM OXALATE 126 47 24 28 18
TRIAZOLAM 126 23 23 B 28 83
VENLAFAXINE HCL 122 33 27 30 50
SEROQUEL XR 120 0 18 A 31 30
ABILIFY 118 14 22 A 32 14
METHYLPHENIDATE HCL 116 39 17 S2 33 51
DEXTROAMPHETAMINE-AMPHETAMINE 106 11 17 S2 34 54
PRISTIQ ER 99 25 16 35 40
TOPIRAMATE 95 13 13 36 45
CHLORPROMAZINE HCL 94 <11 19 A 37 68
TRIHEXYPHENIDYL HCL 85 <11 <11 R 38 53
OXCARBAZEPINE 81 18 13 39 41
DOXEPIN HCL 79 32 11 40 52
PROPRANOLOL HCL 78 20 15 41 56
PROMETHAZINE HCL 77 13 13 R 42 82
BENZTROPINE MESYLATE 74 <11 15 R 43 6
SAPHRIS 67 <11 <11 A 44 64
TRAMADOL HCL 65 <11 13 45 79
ATENOLOL 65 <11 13 45 94
ZIPRASIDONE HCL 58 0 13 A 47 24
BUSPIRONE HCL 55 <11 14 48 34
CYCLOBENZAPRINE HCL 55 12 14 R 48 87
LATUDA 55 <11 <11 A 48 49
FLUVOXAMINE MALEATE 54 <11 <11 51 55
VALPROIC ACID* 54 <11 <11 51 101
CLORAZEPATE DIPOTASSIUM 53 <11 <11 B 53 105
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.